Which hedge funds own CTMX? CYTOMX THERAPEUTICS INC., Q2 2026 13F holders
Healthcare · Open on the interactive board
6 of the hedge funds tracked by WhaleCreep disclosed a position in CTMX (CYTOMX THERAPEUTICS INC.) in their Q2 2026 13F filings, worth $71.4m in total. The largest holder by portfolio weight is Point72 Asset Management LP at 0.0% of its book. 1 manager opened a new position this quarter: Tudor Investment. 1 exited: Brevan Howard Capital Management.
6tracked managers holding
1opened this quarter
1exited this quarter
Which hedge funds hold CTMX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Point72 Asset Management LP | Q2 2026 | 0.0% | $29.3m | 7,811,033 | -1% | reduced |
| Woodline Partners | Q2 2026 | 0.0% | $7.7m | 2,040,210 | 2% | added |
| Tudor Investment | Q2 2026 | 0.0% | $5.2m | 1,380,687 | – | new |
| Marshall Wace | Q2 2026 | 0.0% | $11.3m | 3,024,351 | -27% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $11.7m | 3,110,509 | -42% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $6.3m | 1,685,830 | -54% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management | 0.1% | $1.3m |
How has hedge fund ownership of CTMX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 6 | $71.4m |
| Q1 2026 | 6 | $109.7m |
| Q4 2025 | 2 | $32.1m |
| Q3 2025 | 4 | $37.0m |
| Q2 2025 | 4 | $33.9m |
| Q1 2025 | 4 | $4.1m |
| Q4 2024 | 2 | $4.1m |
| Q3 2024 | 2 | $1.7m |
| Q2 2024 | 1 | $1.4m |
| Q1 2024 | 3 | $4.8m |
| Q4 2023 | 3 | $3.6m |
| Q3 2023 | 3 | $2.5m |
| Q2 2023 | 3 | $3.6m |
| Q1 2023 | 3 | $2.7m |
| Q4 2022 | 3 | $6.3m |
| Q3 2022 | 3 | $6.3m |
Counts every tracked manager that disclosed CTMX in that quarter's filing, including managers that have since stopped filing.